WILMINGTON – Seeking to grow its international market for a skin cream that can treat a variety of conditions from eczema to vitiligo, Incyte has signed a collaboration and license […]
WILMINGTON – Growing Wilmington-area biopharmaceutical firm Incyte has agreed to acquire a North Carolina-based firm working on a new treatment for the skin pigmentation disorder vitiligo in a deal worth […]
WILMINGTON – Incyte secured on Monday the first U.S. Food & Drug Administration approval for a treatment of the skin pigmentation disorder vitiligo, demonstrating the growing strength of the biopharmaceutical […]
WILMINGTON – Incyte announced recently that it has signed a deal with a Japanese dermatological product maker to commercialize its eczema cream in the Asian nation. The quickly growing Alapocas-headquartered […]
© 2023 Delaware Business Times